Registry for Stage 2 Type 1 Diabetes

NCT06481904 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: TZIELD (teplizumab-mzwv)

Sponsor

Sanofi